Changchun High & New Technology Industries Group Inc (SHE:000661) — Market Cap & Net Worth
Market Cap & Net Worth: Changchun High & New Technology Industries Group Inc (000661)
Changchun High & New Technology Industries Group Inc (SHE:000661) has a market capitalization of $4.32 Billion (CN¥29.51 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #3925 globally and #565 in its home market, demonstrating a -3.25% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Changchun High & New Technology Industries Group Inc's stock price CN¥72.33 by its total outstanding shares 407937529 (407.94 Million). Also see 000661 total asset value for a full breakdown of the balance sheet.
Changchun High & New Technology Industries Group Inc Market Cap History: 2015 to 2026
Changchun High & New Technology Industries Group Inc's market capitalization history from 2015 to 2026. Data shows growth from $2.91 Billion to $4.32 Billion (4.37% CAGR). Also see 000661 cash flow metrics for how efficiently the company converts equity into cash flow.
Changchun High & New Technology Industries Group Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Changchun High & New Technology Industries Group Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Changchun High & New Technology Industri stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.46x
Changchun High & New Technology Industries Group Inc's market cap is 0.46 times its annual revenue
Latest Price to Earnings (P/E) Ratio
35.65x
Changchun High & New Technology Industries Group Inc's market cap is 35.65 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.13 Billion | $2.90 Billion | $484.85 Million | 1.08x | 6.45x |
| 2017 | $5.15 Billion | $4.10 Billion | $661.95 Million | 1.26x | 7.78x |
| 2018 | $4.95 Billion | $5.37 Billion | $1.01 Billion | 0.92x | 4.92x |
| 2019 | $12.67 Billion | $7.37 Billion | $1.78 Billion | 1.72x | 7.14x |
| 2020 | $25.49 Billion | $8.58 Billion | $3.05 Billion | 2.97x | 8.37x |
| 2021 | $15.43 Billion | $10.75 Billion | $3.76 Billion | 1.44x | 4.11x |
| 2022 | $9.51 Billion | $12.63 Billion | $4.14 Billion | 0.75x | 2.30x |
| 2023 | $8.38 Billion | $14.57 Billion | $4.53 Billion | 0.58x | 1.85x |
| 2024 | $5.94 Billion | $13.47 Billion | $2.58 Billion | 0.44x | 2.30x |
| 2025 | $5.52 Billion | $12.08 Billion | $154.97 Million | 0.46x | 35.65x |
Competitor Companies of 000661 by Market Capitalization
Companies near Changchun High & New Technology Industries Group Inc in the global market cap rankings as of September 19, 2026. Review how tangible is Changchun High & New Technology Industri's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Changchun High & New Technology Industries Group Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #520 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #619 globally with a market cap of $44.48 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #637 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Haleon plc (NYSE:HLN): Ranked #665 globally with a market cap of $41.22 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #520 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #619 | GALDERMA GROUP AG | NYSE:GALDY | $44.48 Billion | $38.15 |
| #637 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.10 |
| #665 | Haleon plc | NYSE:HLN | $41.22 Billion | $9.36 |
Changchun High & New Technology Industries Group Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Changchun High & New Technology Industries Group Inc's market cap moved from $2.91 Billion to $ 4.32 Billion, with a yearly change of 4.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥4.32 Billion | -21.85% |
| 2025 | CN¥5.52 Billion | -6.93% |
| 2024 | CN¥5.94 Billion | -29.17% |
| 2023 | CN¥8.38 Billion | -11.87% |
| 2022 | CN¥9.51 Billion | -38.39% |
| 2021 | CN¥15.43 Billion | -39.45% |
| 2020 | CN¥25.49 Billion | +101.16% |
| 2019 | CN¥12.67 Billion | +156.11% |
| 2018 | CN¥4.95 Billion | -4.00% |
| 2017 | CN¥5.15 Billion | +64.81% |
| 2016 | CN¥3.13 Billion | +7.37% |
| 2015 | CN¥2.91 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Changchun High & New Technology Industries Group Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.32 Billion USD |
| MoneyControl | $4.32 Billion USD |
| MarketWatch | $4.32 Billion USD |
| marketcap.company | $4.32 Billion USD |
| Reuters | $4.32 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Changchun High & New Technology Industries Group Inc
Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasa… Read more